Index of Online Supplemental
Material for
J. Exp. Med. 10.1084/jem.20080099
Quezeda et al.
• Figure S1 Therapeutic T reg cell depletion increases the absolute number of effector T cells.
• Figure S2 Early intervention with Gvax/anti-CTLA-4 induces tumor rejection, which correlates with T cell infiltration and activation of tumor vasculature.
• Figure S3 In vivo protocol for the adoptive transfer of in vivo–primed T lymphocytes into tumor bearing mice after host conditioning.
• Figure S4 Gvax and anti-CTLA-4 synergize to induce maximal T cell responses during adoptive cell therapy.
